MedTrace Logo

Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients

NCT04771559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2021-08-03

No results posted yet for this study

Summary

The aim of the study is to evaluate the effects and side effects of inactive COVID-19 vaccine in patients with cancer and compare them with the healthy control group.

Conditions

Interventions

OTHER

COVID-19 antibody test

5 cc blood sample from each participant will be taken 4 weeks after the second dose of the COVID-19 vaccine . After blood samples are centrifuged at 2500 rpm for 10 minutes, the separated serum will be backed up in two different ependorphs and stored at -80 or -20 degrees. The samples will be delivered to the working center in a manner suitable for cold chain transport. COVID-19 antibody test will be performed on the blood samples

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • MAHMUT GUMUS, PROF · MEDENIYET UNIVERSITY

  • AHMET BILICI, PROF · Medipol University

  • HACI MEHMET TURK, PROF · BEZMIALEM UNIVERSITY

  • MESUT SEKER, PROF · BEZMIALEM UNIVERSITY

  • AYSE IREM YASIN, MD · BEZMIALEM UNIVERSITY

  • BILGE SUMBUL, ASOC.PROF. · BEZMIALEM UNIVERSITY

  • FAYSAL DANE, PROF · Acibadem University

  • CAGLAYAN GEREDELI, ASOC.PROF. · OKMEYDANI RESEARCH HOSPITAL

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-06-01
Completion
2021-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771559 on ClinicalTrials.gov